2022
DOI: 10.1038/s41598-022-16604-6
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma

Abstract: The incidence of hepatocellular carcinoma (HCC) has increased in these years. DNA damage repair (DDR) pathway is required in response to DNA damage Gene mutations in DDR pathway play an important role in different stages of tumorigenesis and development. Based on the importance of DDR pathway in precision therapy of multiple cancers, we analyzed DDR gene mutations in Chinese patients with HCC. The results showed that (tumor mutation burden) TMB was significantly higher in HCC patients who carried somatic mutat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 25 publications
1
3
0
Order By: Relevance
“…8c) . Mutations detected in muc4 and blm are consistent with previous reports in human HCC 23,25,26 . To our knowledge, the other six hepatic genes mutated (Extended Data Fig.…”
Section: Resultssupporting
confidence: 91%
“…8c) . Mutations detected in muc4 and blm are consistent with previous reports in human HCC 23,25,26 . To our knowledge, the other six hepatic genes mutated (Extended Data Fig.…”
Section: Resultssupporting
confidence: 91%
“…In our immunohistochemical stains for DNA mismatch, MMR proteins demonstrated the loss of MLH1 and PMS expression, compatible with MLH1 truncating mutation. In HCC and intrahepatic cholangiocarcinoma, the frequency of MLH1 mutation was less than 1% and 2.06%, respectively (55,56). Also, a previous report documented that no DNA MMR protein deficiency was observed in 24 cHCC-CCA (56), indicating that DNA MMR protein deficiency is quite rare in primary liver cancers, especially cHCC-CCA.…”
Section: Discussionmentioning
confidence: 91%
“… 102 P/LP germline variants were discovered in 4.2% of the patients overall, with P/LP variants in moderate to high penetrance genes ATM , BLM, BRCA1, NBN, PMS2, and RAD50 detected in HCC. Another study from China 103 examined 381 cancer-associated genes in the germline of 1427 patients with HCC and discovered 3.5% of these patients carried germline variants in ATR, BLM, BRCA1/2, CHEK2, FANCA, FANCC, FANCD2, MSH6, MLH11, MUTYH, PALB2, PMS2, RAD50, and SMARCA4 . The method for calling gene mutations was not described, and the specific variant allele sequences were not reported in this study.…”
Section: Rare Variants In Cancer-associated Genes In Hepatocellular C...mentioning
confidence: 99%